Opponents of federally funded human embryonic stem cell (hESC) research returned to a U.S. appeals court today to argue that such research should be banned, despite two earlier court decisions that it is legal. The discussion suggested that the three-judge panel’s decision may turn on a technical question: whether the court is obliged to defer to its own previous ruling.
In Stem Cell Suit Appeal, Arguments Over Technicalities
